Molecular formula: | C19H27O9P |
Average mass: | 430.390 |
Monoisotopic mass: | 430.139269 |
ChemSpider ID: | 5289970 |
4 of 4 defined stereocentres
Double-bond stereo
(+)-fostriecin
(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-Trihydroxy-3-methyl-1-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]-1,7,9,11-tridecatetraen-4-yl dihydrogen phosphate
[ACD/IUPAC Name](1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-Trihydroxy-3-methyl-1-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]-1,7,9,11-tridecatetraen-4-yldihydrogenphosphat
[German]
[ACD/IUPAC Name]2H-Pyran-2-one, 5,6-dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraen-1-yl]-, (6R)-
[ACD/Index Name]87810-56-8
[RN]Dihydrogénophosphate de (1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-méthyl-1-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]-1,7,9,11-tridécatétraén-4-yle
[French]
[ACD/IUPAC Name]ZO1648L551
[UNII](1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-1-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]trideca-1,7,9,11-tetraen-4-yl dihydrogen phosphate
(6R)-5,6-dihydro-6-[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-2H-pyran-2-one
[(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-1-[(2R)-6-oxo-2,3-dihydropyran-2-yl]trideca-1,7,9,11-tetraen-4-yl] dihydrogen phosphate
[(1R,3R,4Z,6Z,8E)-3,10-dihydroxy-1-[(E,1R)-1-hydroxy-1-methyl-3-[(2R)-6-oxo-2,3-dihydropyran-2-yl]prop-2-enyl]deca-4,6,8-trienyl] dihydrogen phosphate
[(1R,3R,4Z,6Z,8E)-3,10-dihydroxy-1-[(E,1R)-1-hydroxy-3-[(2R)-6-keto-2,3-dihydropyran-2-yl]-1-methyl-prop-2-enyl]deca-4,6,8-trienyl] dihydrogen phosphate
Antibiotic CI 920
Antibiotic CL 1565A
CL 1565A
CL-1565A
FOSTRIECIN
PD 110,161
PD-110,161
Phosphoric acid mono-{3,10-dihydroxy-1-[1-hydroxy-1-methyl-3-(6-oxo-3,6-dihydro-2H-pyran-2-yl)-allyl]-deca-4,6,8-trienyl} ester